447 related articles for article (PubMed ID: 15740930)
41. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
Voiculescu M; Ionescu C; Ismail G
Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
[TBL] [Abstract][Full Text] [Related]
42. QT interval and dispersion differences between normal and prehypertensive patients: effects of autonomic and left ventricular functional and structural changes.
Doğru MT; Güneri M; Tireli E; Sahin O; Celik T; Iyisoy A
Anadolu Kardiyol Derg; 2009 Feb; 9(1):15-22. PubMed ID: 19196568
[TBL] [Abstract][Full Text] [Related]
43. Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis.
Kim HW; Park CW; Shin YS; Kim YS; Shin SJ; Kim YS; Choi EJ; Chang YS; Bang BK
Nephron Clin Pract; 2006; 102(1):c21-9. PubMed ID: 16166802
[TBL] [Abstract][Full Text] [Related]
44. [Risk of arrhythmias in hemodialysis patients vs healthy people].
Milone F; Urso S; Garozzo M; Memeo AM; Volpe G; Battaglia G
G Ital Nefrol; 2004; 21 Suppl 30():S241-6. PubMed ID: 15750993
[TBL] [Abstract][Full Text] [Related]
45. QT dispersion and early arrhythmic risk during acute myocardial infarction.
Ciolli A; Di Lorenzo M; Bevilacqua U; Lo Sardo G; Tripi M; Fidati R; Palamara A
G Ital Cardiol; 1999 Dec; 29(12):1438-44. PubMed ID: 10687106
[TBL] [Abstract][Full Text] [Related]
46. Regression of left ventricular hypertrophy results in improvement of QT dispersion in patients with hypertension.
Karpanou EA; Vyssoulis GP; Psichogios A; Malakou C; Kyrozi EA; Cokkinos DV; Toutouzas PK
Am Heart J; 1998 Nov; 136(5):765-8. PubMed ID: 9812069
[TBL] [Abstract][Full Text] [Related]
47. [Use of nebivolol in patients with mild and moderate hypertension].
Zhigunova LV; Lakhova EL; Iurenev AP
Ter Arkh; 2003; 75(3):59-61. PubMed ID: 12718224
[TBL] [Abstract][Full Text] [Related]
48. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
49. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
Okin PM; Devereux RB; Gerdts E; Snapinn SM; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Lindholm LH; Dahlöf B;
Circulation; 2006 Mar; 113(12):1588-96. PubMed ID: 16534012
[TBL] [Abstract][Full Text] [Related]
50. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
Rubattu S; Sciarretta S; Ciavarella GM; Venturelli V; De Paolis P; Tocci G; De Biase L; Ferrucci A; Volpe M
J Hypertens; 2007 Apr; 25(4):833-9. PubMed ID: 17351376
[TBL] [Abstract][Full Text] [Related]
51. Recent ventricular repolarization markers in resistant hypertension: are they different from the traditional QT interval?
Salles GF; Cardoso CR; Leocadio SM; Muxfeldt ES
Am J Hypertens; 2008 Jan; 21(1):47-53. PubMed ID: 18091743
[TBL] [Abstract][Full Text] [Related]
52. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol.
Celik T; Yuksel UC; Iyisoy A; Kursaklioglu H; Ozcan O; Kilic S; Ozmen N; Isik E
Int J Cardiol; 2007 Mar; 116(2):206-11. PubMed ID: 16822563
[TBL] [Abstract][Full Text] [Related]
53. Prolonged QT interval is associated with blood pressure rather than left ventricular mass in spontaneously hypertensive rats.
Klimas J; Stankovicova T; Kyselovic J; Bacharova L
Clin Exp Hypertens; 2008 Oct; 30(7):475-85. PubMed ID: 18855252
[TBL] [Abstract][Full Text] [Related]
54. B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients.
Almeida P; Azevedo A; Rodrigues R; Dias P; Friões F; Vazquez B; Abreu-Lima C; Bettencourt P; Barros H
Rev Port Cardiol; 2003 Mar; 22(3):327-36. PubMed ID: 12847875
[TBL] [Abstract][Full Text] [Related]
55. Magnetocardiographic study of ventricular repolarization in hypertensive patients with and without left ventricular hypertrophy.
Brisinda D; Meloni AM; Fenici R
Neurol Clin Neurophysiol; 2004 Nov; 2004():13. PubMed ID: 16012643
[TBL] [Abstract][Full Text] [Related]
56. [Increase of the QT interval dispersion in diabetes mellitus].
Lengyel C; Várkonyi T; Boda K; Fazekas T
Orv Hetil; 1997 Feb; 138(6):337-41. PubMed ID: 9082291
[TBL] [Abstract][Full Text] [Related]
57. [QT dispersion in DDD and VVI paced patients after myocardial infarction or with left ventricular hypertrophy].
Lelakowski J; Majewski J; Bednarek J; Machejek J; Pasowicz M; Kapelak B
Pol Merkur Lekarski; 2001 Jul; 11(61):10-3. PubMed ID: 11579820
[TBL] [Abstract][Full Text] [Related]
58. Prevalence of QTc prolongation in adult Nigerians with chronic heart failure.
Kolo PM; Opadijo OG; Omotoso AB; Balogun MO; Araoye MA; Katibi IA
West Afr J Med; 2008 Apr; 27(2):69-73. PubMed ID: 19025017
[TBL] [Abstract][Full Text] [Related]
59. QT dispersion and early arrhythmic risk in acute myocardial infarction.
Mulay DV; Quadri SM
Indian Heart J; 2004; 56(6):636-41. PubMed ID: 15751519
[TBL] [Abstract][Full Text] [Related]
60. Effect of slow coronary flow on electrocardiographic parameters reflecting ventricular heterogeneity.
Sezgin AT; Barutcu I; Ozdemir R; Gullu H; Topal E; Esen AM; Tandogan I; Acikgoz N
Angiology; 2007; 58(3):289-94. PubMed ID: 17626982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
